Cristina M. Karp, Ph.D.
Affiliations: | 2005 | University of Cincinnati, Cincinnati, OH |
Area:
Pharmacology, Molecular BiologyGoogle:
"Cristina Karp"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Arthur R. Buckley | grad student | 2005 | University of Cincinnati | |
| (HRPAP20: A novel tumor progression regulator in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| White E, Karp C, Strohecker AM, et al. (2010) Role of autophagy in suppression of inflammation and cancer. Current Opinion in Cell Biology. 22: 212-7 |
| Bray K, Chen HY, Karp CM, et al. (2009) Bcl-2 modulation to activate apoptosis in prostate cancer. Molecular Cancer Research : McR. 7: 1487-96 |
| Guan J, Lo M, Dockery P, et al. (2009) The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemotherapy and Pharmacology. 64: 463-72 |
| Mathew R, Degenhardt K, Haramaty L, et al. (2008) Immortalized mouse epithelial cell models to study the role of apoptosis in cancer. Methods in Enzymology. 446: 77-106 |
| Doxsee DW, Gout PW, Kurita T, et al. (2007) Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. The Prostate. 67: 162-71 |
| Karp CM, Shukla MN, Buckley DJ, et al. (2007) HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion. Oncogene. 26: 1780-8 |
| DiPaola RS, Dvorzhinski D, May M, et al. (2007) Therapeutic starvation and autophagy in prostate cancer: A new paradigm Journal of Clinical Oncology. 25: 10530-10530 |
| Karp CM, Pan H, Zhang M, et al. (2004) Identification of HRPAP20: a novel phosphoprotein that enhances growth and survival in hormone-responsive tumor cells. Cancer Research. 64: 1016-25 |